Ultragenyx Pharmaceutical
RARE
#3251
Rank
NZ$6.16 B
Marketcap
$63.82
Share price
-4.26%
Change (1 day)
-18.66%
Change (1 year)

Earnings for Ultragenyx Pharmaceutical (RARE)

Earnings in 2024 (TTM): -NZ$0.85 Billion

According to Ultragenyx Pharmaceutical's latest financial reports the company's current earnings are NZ$0.56 Billion. , an increase over its 2023 earnings that were of -NZ$0.96 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Ultragenyx Pharmaceutical from 2013 to 2024

Annual earnings

Year Earnings Change
2024 -NZ$0.89 Billion-6.99%
2023 -NZ$0.96 Billion-17.65%
2022 -NZ$1.17 Billion55.52%
2021 -NZ$0.75 Billion178.53%
2020 -NZ$0.27 Billion-59.64%
2019 -NZ$0.67 Billion1.46%
2018 -NZ$0.66 Billion12.9%
2017 -NZ$0.58 Billion32.63%
2016 -NZ$0.44 Billion67.87%
2015 -NZ$0.27 Billion160.2%
2014 -NZ$0.11 Billion66.64%
2013 -NZ$60.05 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
NZ$0.95 B-207.38%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$50.68 Million-94.30%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$13.22 M-101.49%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$0.36 Billion-60.28%๐Ÿ‡บ๐Ÿ‡ธ USA